What Is Animal Cloning and Is It Real
Yes, cloning animals is real and has been achieved in multiple species since the first cloned mammal, a sheep named Dolly, was created in 1996 by scientists at the Roslin Institute in Scotland. Cloning is a form of asexual reproduction that produces a genetically identical copy of an organism using somatic cell nuclear transfer, where the nucleus of a donor adult cell is inserted into an enucleated egg cell. The resulting embryo is implanted into a surrogate mother, which carries the clone to term. The technology is used in research, agriculture, and conservation, and companies such as ViaGen Pets and Colossal Biosciences now offer commercial cloning services for livestock, pets, and extinct species projects. For background on the science and ethics, see the overview at https://www.nationalgeographic.com/animals/article/cloning-animals-facts.
According to the U.S. Food and Drug Administration, cloned animals and their offspring are as safe to eat as conventionally bred animals, and the agency has cleared them for the food supply. Despite this, cloning remains rare and expensive, with success rates often below 10 percent due to high rates of embryonic loss, placental abnormalities, and early-life health issues in clones. The most commercially successful cloning company, ViaGen, reports cloning hundreds of cattle, pigs, and horses annually, alongside a growing demand for pet cloning services that cost tens of thousands of dollars per animal.
Which Animals Have Been Cloned and by Whom
Since Dolly, scientists have cloned cattle, pigs, goats, deer, horses, cats, dogs, and camels. Notable examples include the cloned bulls Prometea and Puja, created in Italy and China respectively, and Snuppy, the first cloned dog, produced in 2005 by Seoul National University in South Korea. In the conservation space, the U.S. company ViaGen Pets and Equine has offered commercial horse and pet cloning, while Colossal Biosciences, a de-extinction startup backed by investors including the Winklevoss twins, aims to resurrect the woolly mammoth using cloning and gene-editing techniques. For a timeline of cloning milestones, visit https://www.livescience.com/animal-cloning.
In agriculture, cloning is used to replicate elite breeding stock with high milk or meat yields, and companies like Genus plc and ABS Global integrate cloning alongside artificial insemination and embryo transfer to accelerate genetic progress. In biomedical research, cloned pigs are being engineered for xenotransplantation, with the goal of growing organs compatible with human recipients, a field advancing rapidly as of 2024. Regulatory oversight varies by country, with the European Union and the United States maintaining distinct frameworks for the approval and labeling of cloned animals and their products.
What Are the Success Rates and Challenges of Cloning
Cloning success rates remain low, with published studies reporting live birth rates ranging from 1 to 5 percent depending on the species and laboratory. Common complications include large offspring syndrome, immune deficiencies, and premature aging, as observed in some cloned cattle and mice. The high cost of cloning, which can exceed 50,000 dollars for a horse or pet, limits widespread commercial adoption to high-value genetics and niche markets such as elite breeding and pet preservation.
Companies such as Sooam Biotech Research Foundation in South Korea, which holds the record for cloning the most dogs, continue to refine cloning techniques to improve efficiency and animal health outcomes. Advances in epigenetic reprogramming and gene editing, including CRISPR-based tools, are helping reduce developmental failures and genetic abnormalities in cloned embryos. For the latest updates on cloning technology and its applications, see the detailed reporting at https://www.forbes.com/science/cloning/. The field is also monitored by regulatory bodies such as the U.S. Food and Drug Administration, which provides guidance on the safety and oversight of cloned animals and their derivatives.